CClinicalTrials.gg
CompletedNCT07121764Updated Aug 13, 2025

Postoperative Pain Relief in Children: Comparing Caudal Bupivacaine Alone Versus Bupivacaine With Dexmedetomidine for Infra-Umbilical Surgeries Under General Anesthesia

A Phase 4 interventional study of Bupivacaine %0.25 (isobaric) and Dexmedetomidine & Bupivacaine. in Hernia Repair, Orchiopexy and Hypospadias, sponsored by Allama Iqbal Teaching Hospital. Completed at 1 site in Pakistan. Open to participants aged 1 Year to 12 Years. Per ClinicalTrials.gov, last updated 2025-08-13.

Sponsored by Allama Iqbal Teaching Hospital · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2025, registered Aug 2025).
Phase
Phase 4
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Year to 12 Years
Sex
All
01

Study summary

This study is being done to find out which medicine combination provides better pain relief after surgery in children. Children who are having surgery below the belly button (called infra-umbilical surgery) will receive general anesthesia and a type of pain-blocking injection called a caudal block. This block helps reduce pain after surgery.

The study will compare two types of caudal injections:

One group will receive Bupivacaine alone, a commonly used local anesthetic.

The other group will receive Bupivacaine combined with Dexmedetomidine, a medicine that might help the pain relief last longer.

The main question the researchers want to answer is:

Does adding Dexmedetomidine to Bupivacaine increase the duration of pain relief after surgery in children?

Researchers will also look at:

How long it takes before the child needs the first dose of pain medicine after surgery

How much pain medicine is used in the first 24 hours

How long any movement problems (motor block) last

Whether there are any side effects

Each child will be randomly assigned (like flipping a coin) to one of the two groups. The caudal block will be done after the surgery is completed, while the child is still under anesthesia. The nurse assessing the child's pain will not know which medicine the child received.

Children will be monitored for pain using a standard scoring system (FLACC scale) every few hours after surgery. If the pain score is high (7 or more), the child will receive intravenous paracetamol. Researchers will record how long the pain relief lasts, when the first pain medicine is needed, and the total amount of pain medicine used in the first 24 hours.

The study aims to help doctors choose the most effective and safe method to reduce post-surgery pain in children.

02

Conditions studied

  • Hernia Repair
  • Orchiopexy
  • Hypospadias

Browse trials for

Keywords

  • Bupivacaine
  • Dexmedetomidine
  • Caudal block
  • Pediatrics
  • Postoperative analgesia
03

In context

Hypospadias

131 studies on the registry are indexed under Hypospadias; 34 are open to participants now.

This study's enrollment of 60 is below the median of 68 across 102 interventional studies indexed under Hypospadias.

Browse Hypospadias studies →

Lead sponsor

Allama Iqbal Teaching Hospital is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Elective infra-umbilical Surgeries
  • ASA Status I and II

Exclusion criteria

Exclusion Criteria:

  • Chronic systemic illness (cardiovascular, pulmonary or renal disease, hepatic impairment)
  • Allergy to local anesthetics
  • Coagulation disorder
  • Local skin infection
  • Neuropathy
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Monotherapy

    Bupivacaine alone

    Drug: Bupivacaine %0.25 (isobaric)

  • Experimental
    Combination therapy

    Bupivacaine with Dexmedetomidine

    Drug: Dexmedetomidine & Bupivacaine.

Interventions

  • DrugBupivacaine %0.25 (isobaric)

    1 ml/kg of 0.25% Bupivacaine will be used for caudal block.

  • DrugDexmedetomidine & Bupivacaine.

    1 ml/kg of 0.25% Bupivacaine PLUS 1 μg/kg Dexmedetomidine in 1 ml Normal Saline will be used for caudal block.

06

What researchers measure

Primary outcomes

  1. Analgesia Duration

    Duration of post-operative pain free time (hours): time from surgery to FLACC score ≥7 needing rescue analgesia

    Time frame: From surgery to 24-hours post operatively

Other outcomes

  1. Analgesia Consumption

    Total amount (milligrams) of paracetamol consumed

    Time frame: From surgery to 24-hours post operatively

07

Study locations

1 site
  • Allama Iqbal Teaching Hospital
    Dera Ghazi Khan, Punjab Province 32200, Pakistan
08

References and documents

Publications

  • Saadawy I, Boker A, Elshahawy MA, Almazrooa A, Melibary S, Abdellatif AA, Afifi W. Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics. Acta Anaesthesiol Scand. 2009 Feb;53(2):251-6. doi: 10.1111/j.1399-6576.2008.01818.x. Epub 2008 Dec 6. PubMed 19076110 ↗
  • Goyal V, Kubre J, Radhakrishnan K. Dexmedetomidine as an adjuvant to bupivacaine in caudal analgesia in children. Anesth Essays Res. 2016 May-Aug;10(2):227-32. doi: 10.4103/0259-1162.174468. PubMed 27212752 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07121764
Lead sponsor
Allama Iqbal Teaching Hospital
Responsible party
Sajid Ullah (Principal Investigator, Allama Iqbal Teaching Hospital) — Principal investigator
First posted
Aug 13, 2025
Start date
Apr 27, 2025
Primary completion
Jul 26, 2025
Completion
Jul 26, 2025
Last update
Aug 13, 2025

Study contacts

Syed A Abbas Naqvi, FCPS
study chair · Allama Iqbal Teaching Hospital Dera Ghazi Khan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion